Home LiteratureArticle Details
PMID: 6509356 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activity.

Cancer investigation ·Vol. 2 ·No. 6 ·1984-00-00 ·Pages 449-58

Pavlik EJ, Kenady DE, van Nagell JR, Hanson MB, Donaldson ES, Casper S, Garrett D, Smith D, Keaton K, Flanigan RC

Abstract

The chemical stability of doxorubicin in a variety of tissue culture media has been studied by thin layer chromatography (TLC). In all the media examined, authentic doxorubicin was converted to a chemically distinct form as evidenced by the failure of this form to migrate on TLC plates. The rates of conversion were rapid enough (t 1/2 approximately equal to 3 hr) to be of consequence in chemosensitivity determinations, especially if working solutions of doxorubicin were to be routinely made and stored in tissue culture media. The addition of certain antioxidants to media did not prevent the conversion of authentic doxorubicin. However, doxorubicin was quite stable in distilled water. No single component of media was found to be responsible for the conversion of authentic doxorubicin, although arginine, histidine, tyrosine, NaHCO3, and Fe(NO3)3 could each generate a form of doxorubicin which did not migrate in TLC analysis. Purification of the nonmigrating form of doxorubicin demonstrated that in vitro conversion resulted in considerable loss of lethality while antiproliferative activity was retained. These observations provide possible explanations for the variability in chemosensitivity determinations and may explain some of the failures to predict clinical responsiveness.

MeSH Terms
Antioxidants/pharmacology Cell Division/drug effects Cell Line Cell Survival/drug effects Chromatography, Thin Layer Doxorubicin/pharmacology Neoplasms/drug therapy Time Factors
Chemicals
Antioxidants Doxorubicin
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Pavlik E J
Kenady D E
van Nagell J R
Hanson M B
Donaldson E S
Casper S
Garrett D
Smith D
Keaton K
Flanigan R C
Article Info
Journal
Cancer investigation
Abbr.
Cancer Invest
ISSN
0735-7907
Published
1984-00-00
Pages
449-58
Language
English
Region
England
NLM ID
8307154
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com